OUR MISSION

The mission of the Marcus Stroke Network (MSN) is to support member hospitals in delivering stroke care.  We bring stroke specialists to the bedside through remote technology to ensure timely decision-making, quality improvement, and improved outcomes.

THE MSN IS DEFINED BY:

Comprehensive approach
Proven therapies for stroke care
A collaborative approach to continuous quality improvement, including partnering with member hospitals on stroke center certification
30-year history in the development of stroke protocols
Unparalleled track record in stroke research and discovery
Integrated Solutions with hospital platforms
Customized workflow to meet each hospital’s specific needs
Real time communication with participating hospitals to alert us of acute stroke
Continuing education resources

COMMONLY ASKED QUESTIONS

How did the MSN get started?

The MSN is a natural extension of the world-renowned expertise in stroke care of the Marcus Stroke and Neuroscience Center at Grady Hospital. The MSN was created to extend real time expertise into the community.

WHAT OTHERS

ARE SAYING ABOUT US

Telehealth is especially critical in rural and other remote areas that lack sufficient health care services, including specialty care. Dr. Frankel has historically recognized the growing evidence, including many systematic reviews, to support the use of telehealth for stroke patients and healthcare providers with outcomes: showing reduced length of stay; reduced demand on emergency services; improved access to health care; improved quality of services; improved clinical outcomes; decreased stroke mortality.

— Teri Newsome, RN, BBLSS GCASR QI Consultant Pre-hospital & Acute Hospital Care Georgia Department of Public Health

Within the first year of our program, we have seen dramatic improvements in acute stroke treatment, inpatient stroke care, rehabilitation, and beyond. Some of the most profound improvements include decreased arrival to intravenous tPA treatment times (door to needle) and an increase in treatment with intravenous tPA for patients suffering acute ischemic stroke from 18.2% to 100%.

— Christie Lawrence, RT(R) (CT), ASC-BC